BUY Laurus Labs Ltd — Rajesh Palviya, Axis Securities
byRajesh Palviya, Axis SecuritiesHorizon: NA (inferred Intraday)3 Sept 2026, 7:18 am ISTvia Zee Business (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Is Nifty set for a breakout? Analysts see signs of a shift ahead
NewsEt-Markets·31 Aug · 3d ago
1 advisor has an active swing BUY call on this stock, issued in the last 14 days
Advisor consensus · adjacent horizon·25 Aug · 1w ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Laurus Labs
- BUY — Sachin Janardan Sarvade, IDBI Capital Markets and Securities16 Oct 2026 · ~3 months · target ₹2,400 · Active
- BUY — Shivangi Sarda, Motilal Oswal16 Oct 2026 · ~2 weeks · target ₹2,150 · SL hit
- BUY — Nuvama Wealth16 Oct 2026 · ~1 year · target ₹2,520 · Active
- BUY — Shivangi Sarda, Motilal Oswal13 Oct 2026 · ~3 months · target ₹2,100 · SL hit
- BUY — Ansh Jogendra Bhilwar13 Oct 2026 · ~2 weeks · target ₹2,155 · SL hit
More from Rajesh Palviya, Axis Securities
- BUY Sansera Engineering8 Oct 2026 · ~2 weeks · target ₹4,350 · SL hit
- BUY Trent8 Oct 2026 · ~2 weeks · target ₹3,050 · SL hit
- SELL Sun Pharmaceutical Industries5 Oct 2026 · ~3 months · target ₹1,720 · SL hit
- BUY Cipla29 Sept 2026 · ~2 weeks · target ₹1,480 · SL hit
- BUY Zydus Lifesciences29 Sept 2026 · ~2 weeks · target ₹1,280 · SL hit

